ArticleBioengineering (Basel, Switzerland)2026
Longitudinal Forecasting of Retinal Structure and Function Using a Multimodal StyleGAN-Based Architecture.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Generative Adversarial Networks (GANs) have emerged as powerful tools for medical image synthesis and clinical outcome prediction. In ophthalmology, accurate forecasting of Optical Coherence Tomography (OCT) images and best-corrected visual acuity (BCVA) values can significantly enhance patient monitoring and personalized treatment planning. We introduce a multimodal GAN inspired by the StyleGAN architecture, featuring super-resolution modules, a multi-scale patch discriminator, and temporal attention mechanisms. To predict logMAR values, a hybrid deep-shallow LSTM model was jointly trained alongside the image pipeline. Synthesized scans were processed through an EfficientNet-based classifier to predict 16 retinal biomarkers. To ensure subject independence, we employed a 3-fold patient-level cross-validation strategy. The proposed multimodal GAN achieved an SSIM of 0.9264, an FID of 11.9, and a PSNR of 38.1 dB for OCT forecasting. The logMAR module delivered an MAE of 0.052, while the biomarker classifier attained a macro-F1 score of 0.81. Based on logMAR change forecasting, patients were further categorized into Winner, Stabilizer, and Loser outcome groups using a threshold of Δ=0.05, achieving an overall F1 score of 0.84. Our approach effectively forecasts retinal morphology and functional outcomes, providing valuable predictive insights for proactive clinical decision-making in retinal health management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.